Background Height loss is a simple clinical measure associated with increased fracture risk. However, limited data exists on the association between height loss and fracture risk in postmenopausal Korean women. It is unknown whether this association varies with age.
Methods Data on height loss over a 6-year period were collected from a community-based longitudinal follow-up cohort (Ansung cohort of the Korean Genome and Epidemiology Study). Incident fractures were defined based on self-reported fractures after excluding those due to severe trauma or toes/fingers. The association between incident fractures and height loss was investigated using a Cox proportional hazards model.
Results During a median follow-up of 10 years after the second visit, 259/1,806 participants (median age, 64 years) experienced incident fractures. Overall, a 1 standard deviation (SD) decrease in height (1.6 cm/median 5.8 years) was associated with 9% increased risk of fracture (hazard ratio [HR], 1.09; P=0.037), which lost statistical significance after adjustment for covariates. When stratified into age groups (50–59, 60–69, 70 years or older), a 1 SD decrease in height remained a robust predictor of fracture in the 50 to 59 years age group after adjusting for covariates (adjusted hazard ratio [aHR], 1.52; P=0.003), whereas height loss was not an independent predictor of fracture in the 60 to 69 (aHR, 1.06; P=0.333) or the 70 years or older age groups (aHR, 1.05; P=0.700; P for interaction <0.05, for all).
Conclusion Height loss during the previous 6 years was associated with an increased 10-year fracture risk in postmenopausal women in their 50s.
Citations
Citations to this article as recorded by
A Bone Health Optimization Framework for Malaysia: a position paper by the Malaysian Bone Health Optimization Network (MyBONe) Joon-Kiong Lee, Juzaily Fekry Leong, Fu-Yuen Thong, Mohd Ariff Sharifudin, Azlina Amir Abbas, Nur Azree Ferdaus Kamudin, Sanjiv Rampal, Nor Faissal Yasin, Kwong-Weng Loh, Chee-Ken Chan, Paul James Mitchell Archives of Osteoporosis.2024;[Epub] CrossRef
Background Although recent studies comparing various dosages and intervals of vitamin D supplementation have been published, it is yet to be elucidated whether there is an appropriate dose or interval to provide benefit regarding fracture risk. We aimed to assess the published evidence available to date regarding the putative beneficial effects of vitamin D supplements on fractures and falls according to various dosages and intervals.
Methods We performed a meta-analysis of randomized controlled studies reporting associations between vitamin D supplementation and the risks of fractures and falls in PubMed, EMBASE, and Cochrane library. Studies with supplements of ergocalciferol or calcitriol, those with a number of event ≤10, or those with a follow-up duration of less than 6 months were also excluded.
Results Thirty-two studies were included in the final analysis. Vitamin D supplementation with daily dose of 800 to 1,000 mg was associated with lower risks of osteoporotic fracture and fall (pooled relative risk [RR], 0.87; 95% confidence interval [CI], 0.78 to 0.97 and RR, 0.91; 95% CI, 0.85 to 0.98), while studies with <800 or >1,000 mg/day did not. Also, among intervals, daily administration of vitamin D was associated with the reduced risk of falls, while intermittent dose was not. Also, patients with vitamin D deficiency showed a significant risk reduction of falls after vitamin D supplementation.
Conclusion Daily vitamin D dose of 800 to 1,000 IU was the most probable way to reduce the fracture and fall risk. Further studies designed with various regimens and targeted vitamin D levels are required to elucidate the benefits of vitamin D supplements.
Citations
Citations to this article as recorded by
Ukrainian Consensus on Diagnosis and Management of Vitamin D Deficiency in Adults Nataliia Grygorieva, Mykola Tronko, Volodymir Kovalenko, Serhiy Komisarenko, Tetiana Tatarchuk, Ninel Dedukh, Mykola Veliky, Serhiy Strafun, Yulia Komisarenko, Andrii Kalashnikov, Valeria Orlenko, Volodymyr Pankiv, Oleg Shvets, Inna Gogunska, Svitlana Reg Nutrients.2024; 16(2): 270. CrossRef
Vitamin D Supplementation: A Review of the Evidence Arguing for a Daily Dose of 2000 International Units (50 µg) of Vitamin D for Adults in the General Population Pawel Pludowski, William B. Grant, Spyridon N. Karras, Armin Zittermann, Stefan Pilz Nutrients.2024; 16(3): 391. CrossRef
Clinical Characteristics and Outcomes of Limb Fractures in Saudi Children Lamia Aldhbiban, Fai Alhoshan, Raghad Alomari, Shahad A Almatrafi, Yousef Alanazi, Samir Alsayegh, Haifa Y Alfaraidi, Ayman H Jawadi, Fahad N Aljuraibah Cureus.2024;[Epub] CrossRef
The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches Nikhil Gupta, Navjot Kanwar, Anchal Arora, Kavin Khatri, Abhinav Kanwal Clinical Rheumatology.2024; 43(5): 1421. CrossRef
The multi-faceted nature of age-associated osteoporosis A.E. Smit, O.C. Meijer, E.M. Winter Bone Reports.2024; 20: 101750. CrossRef
Vitamin D Deficiency in Patients With Low-Energy Hip Fractures in Accordance With the Mediterranean Paradox Christos Konstantinidis, Ourania Psoma, Christos Kotsias, Vasileios Panagiotopoulos , Sotiris Plakoutsis, Dimitrios Tsiampas, Dimitrios Vardakas, Dimitrios Giotis Cureus.2024;[Epub] CrossRef
Effect of vitamin D, calcium, or combined supplementation on fall prevention: a systematic review and updated network meta-analysis Long Tan, Ruiqian He, Xiaoxue Zheng BMC Geriatrics.2024;[Epub] CrossRef
Analysis of medication treatment for women with osteoporosis: A real-world retrospective study from Chinese tertiary grade A hospital Xiaolei Liu, Zhenling Zhu, Xianli Wang Bone Reports.2024; 21: 101778. CrossRef
New insights into dairy management and the prevention and treatment of osteoporosis: The shift from single nutrient to dairy matrix effects—A review Kaili Wang, Xu Zhao, Sijia Yang, Xiaoxi Qi, Aili Li, Wei Yu Comprehensive Reviews in Food Science and Food Safety.2024;[Epub] CrossRef
The Importance of Vitamin K and the Combination of Vitamins K and D for Calcium Metabolism and Bone Health: A Review Jan O. Aaseth, Trine Elisabeth Finnes, Merete Askim, Jan Alexander Nutrients.2024; 16(15): 2420. CrossRef
The role of anti-osteoporosis drugs in fall risk Gianpaolo Voltan, Nicola Veronese International Journal of Bone Fragility.2024; 4(1): 2. CrossRef
Pharmacologic or genetic interference with atrogene signaling protects against glucocorticoid-induced musculoskeletal and cardiac disease Amy Y. Sato, Meloney Cregor, Kevin McAndrews, Charles A. Schurman, Eric Schaible, Jennifer Shutter, Punit Vyas, Bhawana Adhikari, Monte S. Willis, Marjan Boerma, Tamara Alliston, Teresita Bellido JCI Insight.2024;[Epub] CrossRef
Vitamin D levels and bone mineral density: a prospective cross-sectional analysis of young orthopedic trauma patients at a rural United States trauma center Michael Booth, Kenneth Sabacinski, Colleen Watkins, Erin Butcho, Emilie Kramer, Lukas Meadows, Michelle A. Bramer Journal of Trauma and Injury.2024; 37(4): 276. CrossRef
Association of vitamin and/or nutritional supplements with fall among patients with diabetes: A prospective study based on ACCORD and UK Biobank Lingfang He, Tianqi Ma, Guogang Zhang, Xunjie Cheng, Yongping Bai Frontiers in Nutrition.2023;[Epub] CrossRef
Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs Gavriela Voulgaridou, Sousana K. Papadopoulou, Paraskevi Detopoulou, Despoina Tsoumana, Constantinos Giaginis, Foivi S. Kondyli, Evgenia Lymperaki, Agathi Pritsa Diseases.2023; 11(1): 29. CrossRef
Recent advances in the identification of related factors and preventive strategies of hip fracture Yaohui Yu, Yudan Wang, Xiaoli Hou, Faming Tian Frontiers in Public Health.2023;[Epub] CrossRef
Can Nutrition Contribute to a Reduction in Sarcopenia, Frailty, and Comorbidities in a Super-Aged Society? Sadao Yoshida, Ryo Shiraishi, Yuki Nakayama, Yasuko Taira Nutrients.2023; 15(13): 2991. CrossRef
Safety Profile of Vitamin D in Italy: An Analysis of Spontaneous Reports of Adverse Reactions Related to Drugs and Food Supplements Valentina Maggini, Giada Crescioli, Ilaria Ippoliti, Eugenia Gallo, Francesca Menniti-Ippolito, Adelaide Chiaravalloti, Vittorio Mascherini, Roberto Da Cas, Simona Potenza, Giulia Gritti, Maria Galiulo, Laura Sottosanti, Alfredo Vannacci, Niccolò Lombardi Journal of Clinical Medicine.2023; 12(14): 4726. CrossRef
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly Sabrina Chiloiro, Stefano Frara, Irene Gagliardi, Antonio Bianchi, Antonella Giampietro, Margherita Medici, Agnese Allora, Luigi di Filippo, Maria Rosaria Ambrosio, Alfredo Pontecorvi, Maria Chiara Zatelli, Laura De Marinis, Andrea Giustina The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e58. CrossRef
Proceedings of the 2023 Santa Fe Bone Symposium: Progress and Controversies in the Management of Patients with Skeletal Diseases E. Michael Lewiecki, Teresita Bellido, John P. Bilezikian, Jacques P. Brown, Azeez Farooki, Christopher S. Kovacs, Brendan Lee, William D. Leslie, Michael R. McClung, Mark L. Prasarn, Deborah E. Sellmeyer Journal of Clinical Densitometry.2023; 26(4): 101432. CrossRef
Serum 25-Hydroxyvitamin D Level Is Negatively Associated with Fatigue in Elderly Maintenance Hemodialysis Patients Menglin Pang, Lin Chen, Na Jiang, Mengmeng Jiang, Baofeng Wang, Lili Wang, Xiao-yan Jia Kidney and Blood Pressure Research.2023; 48(1): 231. CrossRef
Vitamin D for Clinical Diseases in Women: An Indispensable Factor in Medicine and Dentistry Dario Calafiore, Leonzio Fortunato, Mario Migliario Journal of Clinical Medicine.2022; 11(11): 3104. CrossRef
Malnutrition in Older Adults—Effect on Falls and Fractures: A Narrative Review Malgorzata Kupisz-Urbanska, Ewa Marcinowska-Suchowierska Nutrients.2022; 14(15): 3123. CrossRef
Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group Thierry Chevalley, Maria Luisa Brandi, Kevin D. Cashman, Etienne Cavalier, Nicholas C. Harvey, Stefania Maggi, Cyrus Cooper, Nasser Al-Daghri, Oliver Bock, Olivier Bruyère, Mario Miguel Rosa, Bernard Cortet, Alfonso J. Cruz-Jentoft, Antonio Cherubini, Bes Aging Clinical and Experimental Research.2022; 34(11): 2603. CrossRef
The Relationship of Osteoporosis with Menopause: Review of Article Hadeel Anwar Alsarraje, *Liqaa Khalel Alhyali International Journal of Research in Medical Sciences and Technology.2022; 14(01): 127. CrossRef